Answers are grounded in this paper and cite their sources.
The Global HIV Vaccine Enterprise convened a workshop in September 2009 to discuss human and viral genetic variation and its impact on future directions for HIV vaccine research and development. The formidable challenges presented by virus and host genetic variability are interrelated and complicate vaccine development. HIV vaccine researchers need to develop innovative approaches that will facilitate addressing these questions in novel ways.
No takes yet. Share an insight, caveat, or question.
McMichael et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: